Usefulness of FDG-PET imaging for the radiotherapy treatment planning of pyothorax-associated lymphoma

Annals of Nuclear Medicine

Volumn 19, Issue 8, 2005, Pages 725-728

  Asakura, Hirofumi ^a   Togami, Taro ^a   Mitani, Masahiro ^a   Takashima, Hitoshi ^a   Yokoe, Koiku ^a   Yamamoto, Yuka ^a   Nishiyama, Yoshihiro ^a   Monden, Toshihide ^a   Toyama, Yoshihiro ^a   Ohkawa, Motoomi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

FDG PET; Pyothorax associated lymphoma; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ANAMNESIS; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; COURSE EVALUATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; MALE; MEDICAL EXAMINATION; NONHODGKIN LYMPHOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PYOTHORAX ASSOCIATED LYMPHOMA; TREATMENT OUTCOME;

AGED; EMPYEMA, PLEURAL; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA, NON-HODGKIN; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 31744432222     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985123     Document Type: Article

References (8)

1. Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K. Pyothorax-associated lymphoma: A review of 106 cases. J Clin Oncol 2002; 20: 4255-4260.
2. Kostakoglu L, Goldsmith SJ. Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Eur J Nucl Med 2000; 27: 1564-1578.
3. Aruga T, Itami J, Nakajima K, Shibata K, Nojo T, Aruga M, et al. Treatment for pyothorax-associated lymphoma. Radiother Oncol 2000; 56: 59-63.
4. Yorke ED, Jackson A, Rosenzweig KE, Merrick SA, Gabrys D, Venkatraman ES, et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002; 54: 329-339.
5. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999; 45: 323-329.
6. Shiroyama H, Koizumi M, Yamashita T. Usefulness of gallium-67 scintigraphy in diagnosing pyothorax-associated lymphoma. KAKU IGAKU (Jpn J Nucl Med) 2001; 38: 223-228.
7. 18F]FDG-PET a valid alternative to conventional diagnostic methods? J Clin Oncol 2001; 19: 414-419.
8. Zinzani PL, Fanti S, Battista G, Tani M, Castellucci P, Stefoni V, et al. Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer 2004; 91: 850-854.